- Tytuł:
-
Efficacy and Safety of CMAB008 Compared with Innovator
Infliximab in Patients with Moderate-to-SevereRheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study. - Autorzy:
- Źródło:
- Rheumatology & Therapy. Jun2023, Vol. 10 Issue 3, p757-773. 17p.
Czasopismo naukowe